Sepha will be introducing its newly patented 3D Leak Detection technology for pharmaceutical blister packs via two live online webinars on the 2nd and 3rd December.

Porvair Sciences reports it has agreed with its collaborative partners to make additional investment in the CEAT project.

NeurodigitX, announced today a new comprehensive platform called Plastic Health.

FairJourney Biologics S.A (FJB) and IONTAS Limited (IONTAS) today announced they have signed an agreement to discover antibodies with Pandion Therapeutics (Pandion).

BioVersys has reached a major milestone by entering clinical development with the start of Phase 1 testing of BV100 in healthy volunteers.

Abcam’s new premium-grade proteins are manufactured in mammalian cell lines under animal-free conditions limiting endotoxins to ultra-low levels (< 5 EU/mg).

CatSci has appointed three key industry thought leaders to its Strategic Advisory Board.

BUCHI is opening a new branch in Spain for further direct distribution.

Intellia Therapeutics, Inc announced that the first patient has been treated with NTLA-2001, which the company is developing as a single-course, potentially curative therapy for transthyretin amyloidosis (ATTR).

Oxford Immunotec Global PLC today announced the release of data from a prospective cohort study in keyworkers in the UK – a collaboration between the Company and Public Health England.